3D Tissue Models
7th Annual In-House Counsel Forum on Government Regulation of Prescription Drug Pricing
New York Marriott East Side Hotel
525 Lexington Ave,
New York,, NY

Schedule of Presentations:

Tuesday, March 10, 2009
09:00:00 Interactive Workshop A – Contracting in a World Without AWP: Preparing for Contract Negotiations Using New Pricing Benchmarks
13:00:00 Interactive Workshop B – Master Class on International Drug Pricing: Understanding How Global Pricing and Reimbursement Systems Impact Overall Pricing Strategies Wayne Critchley
Wednesday, March 11, 2009
07:15:00 Registration and Continental Breakfast
08:15:00 Co-Chairs’ Opening Remarks Ann Flaherty, Larri A Short
08:30:00 Preparing for Potential Changes to AMP and Examining How Those Changes Will Affect the Pricing Sector Don L Bell, II, Benjamin S Martin
09:45:00 Morning Coffee Break
10:00:00 Navigating Compliance Obligations Under New TRICARE Regulations Howard Crawford, Constance A Wilkinson
11:15:00 Resolving Disputes with State Medicaid Programs and CMS
12:15:00 Networking Luncheon
13:30:00 Breakout Session 1 : (A) Tracking the Evolution of MDL 1456 William F Cavanaugh, Jr., Michael L Koon, Tina M Tabacchi
13:30:00 Breakout Session 1 : (B) Mastering the Mechanics and Operational Challenges Associated With the Final DRA Rule Timothy J Nugent, Esther R Scherb, Larri A Short
15:00:00 Afternoon Refreshment Break
15:15:00 Breakout Session 2 : (D) Negative Pricing: When Statutory Discounts Create a Profit Center for Government Programs Curtis Moore, John D Shakow
15:15:00 Breakout Session 2 : (C) Countering Evolving Theories of Liability in AWP Cases Michael C Moore, Jacques D Smith, Raymond C Winter, Daniel “Dee” W Miles, III
16:15:00 Breakout Session 3 : (E) Grappling With The Uncertain Future of AWP: Preparing For the Changing Reimbursement Landscape Christopher Stomberg
16:15:00 Breakout Session 3 : (F) Creating a Robust Pricing Compliance/Audit Program That Will Provide the Most Accurate Calculations and the Ability to Verify Them Lena Robins
17:15:00 Conference Adjourns to Day 3
Thursday, March 12, 2009
08:00:00 Continental Breakfast
09:00:00 Co-Chairs’ Remarks
09:15:00 New Legislative and Regulatory Developments in Drug Pricing Tim Hermes, Kathleen M Weldon, David L Ralston, Steven Stranne
10:30:00 Morning Coffee Break
10:45:00 Identifying Pricing Related Government Enforcement Trends Riza Dagli, Virginia A Gibson, Daniel R Miller, Mitchell J Lazris
12:15:00 Networking Luncheon
13:30:00 Identifying New and Continuing OIG Target Areas Robert A Vito
14:30:00 Afternoon Refreshment Break
14:45:00 Antitrust Considerations in Pricing Harvey Kaish, John Roberti, Scott A Stempel
15:45:00 Insights Into 340B Legislative, Regulatory and Litigation Changes That Will Impact All Pricing Stakeholders Virginia A Gibson
16:45:00 Conference concludes
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.